Impact of tailored anti-P2Y12 therapies in acute coronary syndromes.

about

Impact of tailored anti-P2Y12 therapies in acute coronary syndromes.

Item

http://www.wikidata.org/entity/Q38444425

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Impact of tailored anti-P2Y12 therapies in acute coronary syndromes.

@en

type

Item

label

Impact of tailored anti-P2Y12 therapies in acute coronary syndromes.

@en

prefLabel

Impact of tailored anti-P2Y12 therapies in acute coronary syndromes.

@en

P1476

Impact of tailored anti-P2Y12 therapies in acute coronary syndromes.

@en

P2093

Fabian Stimpfle

http://www.w3.org/2001/XMLSchema#string

Tobias Geisler

http://www.w3.org/2001/XMLSchema#string

P2860

Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding

Response variability to P2Y12 receptor inhibitors: expectations and reality

Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

The Residual Platelet Aggregation after Deployment of Intracoronary Stent (PREDICT) score.

CYP2C19 and nongenetic factors predict poor responsiveness to clopidogrel loading dose after coronary stent implantation.

Early but not late stent thrombosis is influenced by residual platelet aggregation in patients undergoing coronary interventions.

Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis.

Pharmacometabolomics reveals that serotonin is implicated in aspirin response variability

Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy

P304

493-499

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/PGS.15.19

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25916521

http://www.w3.org/2001/XMLSchema#string

Impact of tailored anti-P2Y12 therapies in acute coronary syndromes.

about

Impact of tailored anti-P2Y12 therapies in acute coronary syndromes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698